Table 2.
The risk of insulin resistance according to lipid profiles.
All | Nonobese | Obese | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 1 | Model 2 | Model 1 | Model 2 | |||||||
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
TC (mmol/L) | 1.154 (1.021–1.304) | 0.021 | 1.196 (1.042–1.373) | 0.011 | 1.233 (1.006–1.488) | 0.044 | 1.178 (0.964–1.439) | 0.110 | 1.173 (0.976–1.409) | 0.089 | 1.192 (0.984–1.443) | 0.073 |
TG (mmol/L) | 2.006 (1.764–2.281) | <0.001 | 1.715 (1.499–1.961) | <0.001 | 1.917 (1.590–2.312) | <0.001 | 1.754 (1.442–2.133) | <0.001 | 1.626 (1.353–1.953) | <0.001 | .631 (1.352–1.969) | <0.001 |
LDL-C (mmol/L) | 1.022 (0.888–1.177) | 0.759 | 1.029 (0.879–1.206) | 0.721 | 1.138 (0.909–1.425) | 0.260 | 1.047 (0.829–1.321) | 0.700 | 0.991 (0.804–1.221) | 0.932 | 1.001 (0.806–1.243) | 0.993 |
HDL-C (mmol/L) | 0.133 (0.090–0.197) | <0.001 | 0.250 (0.161–0.388) | <0.001 | 0.127 (0.068–0.237) | <0.001 | 0.197 (0.103–0.379) | <0.001 | 0.336 (0.187–0.603) | <0.001 | 0.348 (0.189–0.640) | 0.001 |
Non-HDL-C (mmol/L) | 1.497 (1.318–1.700) | <0.001 | 1.420 (1.231–1.639) | <0.001 | 1.576 (1.296–1.917) | <0.001 | 1.426 (1.163–1.749) | 0.001 | 1.350 (1.109–1.643) | 0.003 | 1.371 (1.117–1.684) | 0.003 |
LDL-C/HDL-C | 1.762 (1.507–2.059) | <0.001 | 1.488 (1.252–1.768) | <0.001 | 1.940 (1.524–2.471) | <0.001 | 1.618 (1.258–2.081) | <0.001 | 1.318 (1.041–1.670) | 0.022 | 1.329 (1.039–1.699) | 0.023 |
TC/HDL-C | 1.907 (1.706–2.132) | <0.001 | 1.672 (1.462–1.912) | <0.001 | 1.976 (1.678–2.326) | <0.001 | 1.741 (1.434–2.114) | <0.001 | 1.505 (1.268–1.787) | <0.001 | 1.564 (1.292–1.893) | <0.001 |
TG/HDL-C | 1.927 (1.711–2.171) | <0.001 | 1.650 (1.458–1.867) | <0.001 | 1.894 (1.588–2.259) | <0.001 | 1.704 (1.420–2.047) | <0.001 | 1.544 (1.307–1.823) | <0.001 | 1.560 (1.316–1.848) | <0.001 |
Data are odds ratios (95% confidence interval); model 1 is adjusted for age and sex; model 2 is further adjusted for BMI, SBP, and DBP.